{"id":23191,"date":"2026-03-26T05:19:00","date_gmt":"2026-03-26T09:19:00","guid":{"rendered":"https:\/\/dbv-technologies.com\/press_releases\/dbv-technologies-publie-son-form-10-k-americain-et-son-document-denregistrement-universel-2025\/"},"modified":"2026-03-26T05:19:00","modified_gmt":"2026-03-26T09:19:00","slug":"dbv-technologies-publie-son-form-10-k-americain-et-son-document-denregistrement-universel-2025","status":"publish","type":"press_releases","link":"https:\/\/dbv-technologies.com\/fr\/press_releases\/dbv-technologies-publie-son-form-10-k-americain-et-son-document-denregistrement-universel-2025\/","title":{"rendered":"DBV Technologies publie son \u00ab\u00a0Form 10-K\u00a0\u00bb am\u00e9ricain et son Document d\u2019Enregistrement Universel 2025"},"content":{"rendered":"<div class=\"pr-date-globe\">March 26, 2026 17:19 ET<\/div>\n<p align=\"right\">Ch\u00e2tillon, France, le 26 mars 2026<\/p>\n<p align=\"justify\"><b>DBV Technologies publie son \u00ab&nbsp;Form 10-K&nbsp;\u00bb am\u00e9ricain et son Document d\u2019Enregistrement Universel 2025<\/b><\/p>\n<p align=\"justify\">DBV Technologies &lpar;Euronext : DBV \u2013 ISIN&nbsp;: FR0010417345 &#8211; Nasdaq&nbsp;: DBVT), une soci\u00e9t\u00e9 biopharmaceutique de stade avanc\u00e9 &lpar;la \u00ab&nbsp;Soci\u00e9t\u00e9&nbsp;\u00bb), a annonc\u00e9 aujourd&rsquo;hui, au titre de l\u2019exercice 2025, que&nbsp;le \u00ab&nbsp;Form 10-K&nbsp;\u00bb a \u00e9t\u00e9 d\u00e9pos\u00e9 aupr\u00e8s de la Securities and Exchange Commission&nbsp;&lpar;\u00ab&nbsp;SEC&nbsp;\u00bb) aux Etats-Unis, ainsi que le document d\u2019enregistrement universel &lpar;\u00ab&nbsp;DEU 2025 \u00bb), aupr\u00e8s de l\u2019Autorit\u00e9 des March\u00e9s Financiers &lpar;\u00ab&nbsp;AMF&nbsp;\u00bb) en France.<\/p>\n<p align=\"justify\">Les informations suivantes sont int\u00e9gr\u00e9es dans le DEU 2025 : <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify;\">le rapport financier annuel 2025; <\/li>\n<li style=\"text-align:justify;\">le rapport sur le gouvernement d\u2019entreprise pr\u00e9vu \u00e0 l\u2019article L. 225-37 du Code de commerce&nbsp;;<\/li>\n<li style=\"text-align:justify;\">le descriptif du programme de rachat d\u2019actions&nbsp;;<\/li>\n<li style=\"text-align:justify;\">les rapports des commissaires aux comptes&nbsp;;<\/li>\n<li style=\"text-align:justify;\">les informations relatives aux honoraires des commissaires aux comptes.\n<\/li>\n<\/ul>\n<p align=\"justify\">Les documents peuvent \u00eatre consult\u00e9s sur le site internet de la Soci\u00e9t\u00e9, \u00e0 l\u2019adresse <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LqoGUSoTC9UycEucYc0PQ62I5Oy_Opu1oagPWHlRCEh2R7l23pjTGq5uap4ioaYIsBFmELEmTcxCXCHs-P-EFkD857_JJArxkg-JbnG4i9CRgAC5KPxeeiyOEMyOmS4X\" rel=\"nofollow\" target=\"_blank\" title=\"www.dbv-technologies.com\">www.dbv-technologies.com<\/a> dans la section Informations R\u00e9glement\u00e9es. <br \/>Le Form 10-K est \u00e9galement disponible sur le site internet de la SEC &lpar;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LqoGUSoTC9UycEucYc0PQwGKHOKFAOY4Djog1zng6LyWBMr54sFq3Cz1-s0jc02OjAyh5-a2NWHg0JiRunMhRw==\" rel=\"nofollow\" target=\"_blank\" title=\"www.sec.gov\">www.sec.gov<\/a>), et le DEU 2025 sur le site internet de l\u2019AMF &lpar;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LqoGUSoTC9UycEucYc0PQ2cbKg0JAtBHYn27pneRlumGnpmUlfJ7ctH6yfgpSIhsD25my_aQYhGqdl_7lLbRh6faNV-GLhZV4ty2tTeOsdM=\" rel=\"nofollow\" target=\"_blank\" title=\"www.amf-france.org\">www.amf-france.org<\/a>).<\/p>\n<p align=\"justify\"><b>A propos de DBV Technologies&nbsp;<\/b><br \/>DBV Technologies est une entreprise biopharmaceutique de stade avanc\u00e9 sp\u00e9cialis\u00e9e dans le d\u00e9veloppement d\u2019options de traitement des allergies alimentaires et autres affections immunologiques ayant d\u2019importants besoins m\u00e9dicaux non satisfaits. DBV Technologies se concentre actuellement sur l\u2019\u00e9tude de l\u2019utilisation de sa technologie exclusive, le patch VIASKIN\u00ae, pour traiter les allergies alimentaires caus\u00e9es par une r\u00e9action immunitaire hypersensible et caract\u00e9ris\u00e9es par une gamme de sympt\u00f4mes dont la gravit\u00e9 varie de l\u00e9g\u00e8re \u00e0 l\u2019anaphylaxie potentiellement mortelle. Des millions de personnes vivent avec des allergies alimentaires, y compris de jeunes enfants. Gr\u00e2ce \u00e0 l\u2019immunoth\u00e9rapie \u00e9picutan\u00e9e &lpar;EPIT), le patch VIASKIN<sup>\u00ae<\/sup> est con\u00e7u pour dispenser des quantit\u00e9s de microgrammes d\u2019un compos\u00e9 biologiquement actif dans le syst\u00e8me immunitaire \u00e0 travers une peau intacte. L\u2019EPIT est une nouvelle classe de traitement non invasif cherchant \u00e0 modifier l\u2019allergie sous-jacente d\u2019un individu en r\u00e9\u00e9duquant le syst\u00e8me immunitaire \u00e0 se d\u00e9sensibiliser \u00e0 l\u2019allerg\u00e8ne en tirant parti des propri\u00e9t\u00e9s de tol\u00e9rance immunitaire de la peau. DBV Technologies s\u2019est engag\u00e9e \u00e0 transformer le traitement des personnes souffrant d\u2019allergies alimentaires. Les programmes d\u2019allergie alimentaire de la Soci\u00e9t\u00e9 comprennent des \u00e9tudes cliniques en cours avec le patch VIASKIN<sup>\u00ae<\/sup> peanut chez les jeunes enfants &lpar;de 1 \u00e0 3 ans) et les enfants &lpar;de 4 \u00e0 7 ans) allergiques \u00e0 l\u2019arachide. <\/p>\n<p align=\"justify\">Le si\u00e8ge mondial de DBV Technologies est situ\u00e9 \u00e0 Ch\u00e2tillon, en France, avec des op\u00e9rations nord-am\u00e9ricaines bas\u00e9es \u00e0 Warren, dans le New Jersey. Les actions ordinaires de la Soci\u00e9t\u00e9 sont n\u00e9goci\u00e9es sur le compartiment B d\u2019Euronext Paris &lpar;symbole : DBV, code ISIN : FR0010417345) et les ADS de la Soci\u00e9t\u00e9 &lpar;repr\u00e9sentant chacun cinq actions ordinaires) sont n\u00e9goci\u00e9s sur le Nasdaq Capital Market &lpar;DBVT \u2013 CUSIP : 23306J309). <\/p>\n<p align=\"justify\">Pour plus d\u2019informations, veuillez consulter&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LqoGUSoTC9UycEucYc0PQ62I5Oy_Opu1oagPWHlRCEi8JEpjN2i_rSTiOrZbhWH1Qo9CR099ybxPHvMAQvVLjwi4o0va9wHLibPkSLw8Fcsts8oZivWFKIRVxwjGGqqHn1u2wZAEBTeUiwFJzzSEq1gR1A_x3bi4e6jxoRZJc23v4fQIZy3rgGosscS8O1QHgOs-GfoLY0yb3I6Z_T14kKUfhqKxhxBHBmhFEMJBrtBaRMwxTfx0lawkv8jt-tO3XJ4VBWQjagbDRwSRQYAM62ZeU5lGzXcQ9gnd_DI5vKg=\" rel=\"nofollow\" target=\"_blank\" title=\"www.dbv-technologies.com\">www.dbv-technologies.com<\/a>&nbsp;et nous contacter sur&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8dxCUUn1uKtIWLZMzsIcUgFKRZ-OLgLPy55qqnPo1yqkiqLMlzj76TrFTceY0K2Q7eSVxFXXUJ3cnVwQrNEtmmqZooXqR1srMwQZ-Aoklv8JbO3OH6M34915vBBj9DyNEFKU02NeQxqEe0EtqVod8MjbeYH6lNoqgUJ_hRqchTp2e-JdCAh1XUTh7weKfziSHRlMA63VKSOtF_fodcpsirPTu1f4VrofFbgPMSieW3pEs9_xTbGiOh8WjtHuBQmzImDWFUc5XoKFnsKgl83XieUt5-9-ck6OY-4QQw0j69o=\" rel=\"nofollow\" target=\"_blank\" title=\"X &lpar;formerly Twitter)\">X &lpar;formerly Twitter)<\/a>&nbsp;et&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Y3ZfMrWbmNxS_r3UuVKMtJ4Fztu-74xgLCoXcIBwL1k7H3illSZHda8xSviJzBaci2pBWLBeK6KWISFTun73xLZgg1jnGIo2bulgZs5sAnT3_0HcZYt-SAfGry8qo67lTr4SA4uneqJnaz4W74B5FYZwcx1-p8JYTWr75gg9GSFrF_v1uLatnWbysCgOuBujZ-z60ZjbWupAFvyhj-hUsbrRbgxpb1Q01qC-BEN17JAwcs9cuV80-5-slY_IM8FimO2qhJkWYl7g0EO-l60toQ==\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\"><b>Contact avec les investisseurs <\/b><br \/>Jonathan Neely<br \/>DBV&nbsp;Technologies<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lU7ysfAM_O8bflDcOkEjxdMiu398XViPiKThk9EQmmRTWd28nCDI3eXwlWxzJszaqlgs3x4YXMNuM9KIfAmdKPdngueFiAnmAr-lloBSkrVK98lb-GE7JKrpIY3ouCS5NxWMrfv8AQH7BcupeQaoug==\" rel=\"nofollow\" target=\"_blank\" title=\"jonathan.neely@dbv-technologies.com\">jonathan.neely@dbv-technologies.com<\/a> <\/p>\n<p align=\"justify\"><b>Contact avec les m\u00e9dias<\/b><br \/>Brett Whelan<br \/>DBV&nbsp;Technologies<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qGLDtZimeiZKNSfFa9XilBw35VQqPEmvdUjglWNxCknoUDLamAIK8VDA91Qi6PPVsZjkkVomMvIm5W2sV7pvRYaREhzy27v-oOp0EXwuHFB6-dn0bMYgEwiZy5elKEF0Sv84zm1LQAp6cJpJ2IKECQ==\" rel=\"nofollow\" target=\"_blank\" title=\"brett.whelan@dbv-technologies.com\">brett.whelan@dbv-technologies.com<\/a><\/p>\n<p id=\"gnw_attachments_section-header\">    <strong>Pi\u00e8ce jointe<\/strong><\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=EyqhDvDebKvK9leV8qf5u9cFnLUoY9WcOs_SnOhpMtTGIyO7gvCU-h5MoVXdJweZtoh9jg6A4_omo-ur9IhtXTAUxNewyWWR8Zsmwh9-4_wArnOVV81bt8SBcTXWkyNmdKGQQmlb8yCSaAiLBH8jEdTtpgLJj9P7a-LoIjPKCjY=\" title=\"version PDF\" rel=\"nofollow\">version PDF<\/a>      <\/li>\n<\/ul>\n<p><img decoding=\"async\" alt=\"\" data-src=\"https:\/\/ml-eu.globenewswire.com\/media\/ZTllZTY1ZGYtODM2My00NGJkLThlODItNjAwZDAyMmQ1OGIxLTEwMTExNTItMjAyNi0wMy0yNi1mcg==\/tiny\/DBV-Technologies-S-A-.png\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\">            <\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"wds_primary_press_release_type":0,"footnotes":""},"press_release_type":[],"class_list":["post-23191","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/23191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/types\/press_releases"}],"version-history":[{"count":0,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/23191\/revisions"}],"wp:attachment":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/media?parent=23191"}],"wp:term":[{"taxonomy":"press_release_type","embeddable":true,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_release_type?post=23191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}